Timolol maleate 0.5% eye drop UD 60S
Ended Awarded
- Contract number
- SPE2DB25FX30B
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,574
Award facts
- Contract value 100% obligated
- $1,573.73 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Timolol Maleate 0.5% eye drop unit dose formulations (60 count) with a ceiling value of $1,573.73. This non-set-aside delivery order was awarded on August 13, 2025, with an ultimate completion date of August 14, 2025, and carries firm fixed pricing. The product will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. This prime vendor contract serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, maintains a significant federal contracting presence with the Defense Logistics Agency and supports critical medical supply chains for military and veteran healthcare systems. The company has demonstrated capability to fulfill federal procurement requirements through competitive awards across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies. The current delivery order represents routine pharmaceutical procurement consistent with the company's extensive portfolio of federal medical product deliveries, serving end-users such as the Defense Health Agency and U.S. Coast Guard through DLA's comprehensive contract vehicle.
Quick answers
Who was awarded contract SPE2DB25FX30B?
SPE2DB25FX30B was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 13, 2025.
How much is contract SPE2DB25FX30B worth?
The government has obligated $1,574 on SPE2DB25FX30B.
Is contract SPE2DB25FX30B an order under another contract?
Yes. SPE2DB25FX30B is a delivery order under SPE2DB20D2200, an indefinite delivery contract.
Was contract SPE2DB25FX30B competed?
The extent of competition for SPE2DB25FX30B was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award